These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31225749)

  • 1. CRISPR-Cas3 Adds a Power Saw to the Toolbox for Human Genome Engineering.
    Hatoum-Aslan A
    CRISPR J; 2019 Jun; 2():150-152. PubMed ID: 31225749
    [No Abstract]   [Full Text] [Related]  

  • 2. Cas11 enables genome engineering in human cells with compact CRISPR-Cas3 systems.
    Tan R; Krueger RK; Gramelspacher MJ; Zhou X; Xiao Y; Ke A; Hou Z; Zhang Y
    Mol Cell; 2022 Feb; 82(4):852-867.e5. PubMed ID: 35051351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome editing: The domestication of Cas9.
    Urnov F
    Nature; 2016 Jan; 529(7587):468-9. PubMed ID: 26819037
    [No Abstract]   [Full Text] [Related]  

  • 4. Calls for caution in genome engineering should be a model for similar dialogue on pandemic pathogen research.
    Lipsitch M; Esvelt K; Inglesby T
    Ann Intern Med; 2015 Nov; 163(10):790-1. PubMed ID: 26344802
    [No Abstract]   [Full Text] [Related]  

  • 5. CRISPR-Cas9 knockout screening for functional genomics.
    Shen Z; Ou G
    Sci China Life Sci; 2014 Jul; 57(7):733-4. PubMed ID: 25005538
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progress of genome engineering technology via clustered regularly interspaced short palindromic repeats--a review].
    Li H; Qiu S; Song H
    Wei Sheng Wu Xue Bao; 2013 Oct; 53(10):1025-30. PubMed ID: 24409757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cas3-stimulated runaway replication of modified ColE1 plasmids in Escherichia coli is temperature dependent.
    Radovčić M; Čulo A; Ivančić-Baće I
    FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31095294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas3 induces broad and unidirectional genome editing in human cells.
    Morisaka H; Yoshimi K; Okuzaki Y; Gee P; Kunihiro Y; Sonpho E; Xu H; Sasakawa N; Naito Y; Nakada S; Yamamoto T; Sano S; Hotta A; Takeda J; Mashimo T
    Nat Commun; 2019 Dec; 10(1):5302. PubMed ID: 31811138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The iCRISPR platform for rapid genome editing in human pluripotent stem cells.
    Zhu Z; González F; Huangfu D
    Methods Enzymol; 2014; 546():215-50. PubMed ID: 25398343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycine Cleavage System and cAMP Receptor Protein Co-Regulate CRISPR/
    Yang D; Wang Z; Ma J; Fu Q; Wu L; Wang H; Wang S; Yan Y; Sun J
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31941083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3.
    Gong B; Shin M; Sun J; Jung CH; Bolt EL; van der Oost J; Kim JS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16359-64. PubMed ID: 25368186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is CRISPR/Cas9?
    Redman M; King A; Watson C; King D
    Arch Dis Child Educ Pract Ed; 2016 Aug; 101(4):213-5. PubMed ID: 27059283
    [No Abstract]   [Full Text] [Related]  

  • 13. More specific CRISPR editing.
    de Souza N
    Nat Methods; 2014 Jul; 11(7):712. PubMed ID: 25110782
    [No Abstract]   [Full Text] [Related]  

  • 14. Genome Editing in Retinal Diseases using CRISPR Technology.
    Yiu G
    Ophthalmol Retina; 2018 Jan; 2(1):1-3. PubMed ID: 31047294
    [No Abstract]   [Full Text] [Related]  

  • 15. Engineering Cas9.
    Rusk N
    Nat Methods; 2015 Aug; 12(8):709. PubMed ID: 26451425
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic screens and functional genomics using CRISPR/Cas9 technology.
    Hartenian E; Doench JG
    FEBS J; 2015 Apr; 282(8):1383-93. PubMed ID: 25728500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods in Enzymology. The use of CRISPR/Cas9, ZFNs, and TALENs in generating site-specific genome alterations. Preface.
    Doudna JA; Sontheimer EJ
    Methods Enzymol; 2014; 546():xix-xx. PubMed ID: 25398356
    [No Abstract]   [Full Text] [Related]  

  • 18. Fitting CRISPR-associated Cas3 into the helicase family tree.
    Jackson RN; Lavin M; Carter J; Wiedenheft B
    Curr Opin Struct Biol; 2014 Feb; 24():106-14. PubMed ID: 24480304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19.
    Zaami S; Piergentili R; Marinelli E; Montanari Vergallo G
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1752-1761. PubMed ID: 33629345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Battling CRISPR-Cas9 off-target genome editing.
    Li D; Zhou H; Zeng X
    Cell Biol Toxicol; 2019 Oct; 35(5):403-406. PubMed ID: 31313008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.